{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T10:10:12Z","timestamp":1789899012785,"version":"4.0.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtm.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T20:02:16Z","timestamp":1549828936000},"page":"265-273","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia"],"prefix":"10.1016","volume":"13","author":[{"given":"Hye-Ri","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Waskowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M.","family":"Seifts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dustin J.","family":"Landau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight D.","family":"Koeberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.02.002_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type\u00a0I\u00a0and G6Pase-\u03b2 deficiency: etiology and therapy","volume":"6","author":"Chou","year":"2010","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.omtm.2019.02.002_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.tem.2009.02.003","article-title":"Emerging therapies for glycogen storage disease type I","volume":"20","author":"Koeberl","year":"2009","journal-title":"Trends Endocrinol. Metab."},{"issue":"Suppl 1","key":"10.1016\/j.omtm.2019.02.002_bib3","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/BF02072090","article-title":"Type I glycogen storage disease: nine years of management with cornstarch","volume":"152","author":"Chen","year":"1993","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.omtm.2019.02.002_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"10.1016\/j.omtm.2019.02.002_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1093\/ajcn\/52.6.1051","article-title":"Physical growth and development of children with type 1 glycogen-storage disease: comparison of the effects of long-term use of dextrose and uncooked cornstarch","volume":"52","author":"Wolfsdorf","year":"1990","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.omtm.2019.02.002_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10545-007-0519-9","article-title":"Glycogen storage disease types I and II: treatment updates","volume":"30","author":"Koeberl","year":"2007","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.omtm.2019.02.002_bib7","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cts.12466","article-title":"Gene therapy 2017: progress and future directions","volume":"10","author":"Keeler","year":"2017","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.omtm.2019.02.002_bib8","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1128\/jvi.71.8.5932-5941.1997","article-title":"Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration","volume":"71","author":"Halbert","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.02.002_bib9","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1128\/JVI.74.3.1524-1532.2000","article-title":"Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes","volume":"74","author":"Halbert","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2019.02.002_bib10","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1089\/hum.2011.106","article-title":"Long-term efficacy following readministration of an adeno-associated virus vector in dogs with glycogen storage disease type Ia","volume":"23","author":"Demaster","year":"2012","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib11","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/hum.2009.157","article-title":"Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia","volume":"21","author":"Weinstein","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib12","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1038\/sj.gt.3302774","article-title":"Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia","volume":"13","author":"Koeberl","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/mt.2008.72","article-title":"Gene delivery to the juvenile mouse liver using AAV2\/8 vectors","volume":"16","author":"Cunningham","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/mt.2010.64","article-title":"Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy","volume":"18","author":"Yiu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/mt.2016.35","article-title":"In\u00a0vivo zinc finger nuclease-mediated targeted integration of a glucose-6-phosphatase transgene promotes survival in mice with glycogen storage disease type IA","volume":"24","author":"Landau","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ymgme.2009.04.003","article-title":"Activation of glycolysis and apoptosis in glycogen storage disease type Ia","volume":"97","author":"Sun","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.omtm.2019.02.002_bib17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10059-009-0126-8","article-title":"Cell death and stress signaling in glycogen storage disease type I","volume":"28","author":"Kim","year":"2009","journal-title":"Mol. Cells"},{"key":"10.1016\/j.omtm.2019.02.002_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41580-018-0003-4","article-title":"Mechanism and medical implications of mammalian autophagy","volume":"19","author":"Dikic","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.omtm.2019.02.002_bib19","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4161\/auto.7.7.15371","article-title":"Liver autophagy contributes to the maintenance of blood glucose and amino acid levels","volume":"7","author":"Ezaki","year":"2011","journal-title":"Autophagy"},{"key":"10.1016\/j.omtm.2019.02.002_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.29176","article-title":"Autophagy determines efficiency of liver-directed gene therapy with adeno-associated viral vectors","volume":"66","author":"H\u00f6sel","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2019.02.002_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: from orphan receptors to drug discovery","volume":"43","author":"Willson","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.omtm.2019.02.002_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/cr.2010.13","article-title":"PPARs: diverse regulators in energy metabolism and metabolic diseases","volume":"20","author":"Wang","year":"2010","journal-title":"Cell Res."},{"key":"10.1016\/j.omtm.2019.02.002_bib23","doi-asserted-by":"crossref","first-page":"e1006819","DOI":"10.1371\/journal.pgen.1006819","article-title":"Downregulation of SIRT1 signaling underlies hepatic autophagy impairment in glycogen storage disease type Ia","volume":"13","author":"Cho","year":"2017","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtm.2019.02.002_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nature13961","article-title":"Nutrient-sensing nuclear receptors coordinate autophagy","volume":"516","author":"Lee","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.02.002_bib25","doi-asserted-by":"crossref","first-page":"193","DOI":"10.6065\/apem.2016.21.4.193","article-title":"Transcriptional coordination of hepatic autophagy by nutrient-sensing nuclear receptor PPAR\u03b1 and FXR","volume":"21","author":"Lee","year":"2016","journal-title":"Ann. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.omtm.2019.02.002_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2015.10.008","article-title":"Induction of autophagy improves hepatic lipid metabolism in glucose-6-phosphatase deficiency","volume":"64","author":"Farah","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.omtm.2019.02.002_bib27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/hmg\/ddy343","article-title":"Bezafibrate induces autophagy and improves hepatic lipid metabolism in glycogen storage disease type Ia","volume":"28","author":"Waskowicz","year":"2019","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2019.02.002_bib28","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/mt.2008.15","article-title":"AAV vector-mediated reversal of hypoglycemia in canine and murine glycogen storage disease type Ia","volume":"16","author":"Koeberl","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtm.2019.02.002_bib30","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/mt.2011.126","article-title":"Hepatorenal correction in murine glycogen storage disease type I with a double-stranded adeno-associated virus vector","volume":"19","author":"Luo","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib31","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1067\/mpd.2001.111322","article-title":"Decreased urinary citrate excretion in type 1a glycogen storage disease","volume":"138","author":"Weinstein","year":"2001","journal-title":"J.\u00a0Pediatr."},{"key":"10.1016\/j.omtm.2019.02.002_bib32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1096\/fj.12-207472","article-title":"Adjunctive \u03b22-agonists reverse neuromuscular involvement in murine Pompe disease","volume":"27","author":"Li","year":"2013","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2019.02.002_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/hum.2015.033","article-title":"Synergistic efficacy from gene therapy with coreceptor blockade and a \u03b22-agonist in murine Pompe disease","volume":"26","author":"Han","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymthe.2017.12.008","article-title":"Combination therapy is the new gene therapy?","volume":"26","author":"Ronzitti","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature10177","article-title":"In\u00a0vivo genome editing restores haemostasis in a mouse model of haemophilia","volume":"475","author":"Li","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.omtm.2019.02.002_bib36","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.gt.3302650","article-title":"Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer","volume":"13","author":"Ghosh","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2019.02.002_bib37","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1002\/hep.25717","article-title":"Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.omtm.2019.02.002_bib38","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1177\/38.10.2169492","article-title":"Quantitative histochemical analysis of glucose-6-phosphatase activity in rat liver using an optimized cerium-diaminobenzidine method","volume":"38","author":"Jonges","year":"1990","journal-title":"J.\u00a0Histochem. Cytochem."},{"key":"10.1016\/j.omtm.2019.02.002_bib39","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1093\/nar\/gkr1214","article-title":"Gene targeting to the ROSA26 locus directed by engineered zinc finger nucleases","volume":"40","author":"Perez-Pinera","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtm.2019.02.002_bib40","series-title":"\u201cOrganic Acid Analysis\u201d in Techniques in Diagnostic Human Biochemical Genetics: A Laboratory Manual","first-page":"143","author":"Sweetman","year":"1991"},{"key":"10.1016\/j.omtm.2019.02.002_bib41","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/GIM.0b013e3181a87867","article-title":"Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker","volume":"11","author":"Young","year":"2009","journal-title":"Genet. Med."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:24Z","timestamp":1762421004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119300191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":41,"alternative-id":["S2329050119300191"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.02.002","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors.","name":"copyright","label":"Copyright"}]}}